Paul Aisen, MD - Alzheimer's Clinical Trials Consortium

Michael S. Rafii, MD, PhD on LinkedIn: Alzheimer's meds are here. But for the Down syndrome community, it's still…

PDF) Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future

USC's Paul Aisen, pioneering Alzheimer's researcher, honored with Epstein Alzheimer's Disease Director's Chair

Clinical

A deep learning framework identifies dimensional representations of Alzheimer's Disease from brain structure

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease, Alzheimer's Research & Therapy

Antibodies, Free Full-Text

Detect Alzheimer's disease before memory loss

Projects - Alzheimer's Clinical Trials Consortium

Paul Aisen, MD - Keck School of Medicine of USC

About Us - Alzheimer's Clinical Trials Consortium

Georgetown Study Explores THC/CBD Combination to Reduce Dementia-related Agitation at the End of Life, Georgetown University Medical Center

ADNI 3 Clinical Core Plans - ppt download

Paul Aisen, MD - Alzheimer's Clinical Trials Consortium